EN DE
STOCK COMPARISON

NexturnBioscience Co. vs NIBE Industrier AB (publ): Fair Value & Quality

Both stocks run through our valuation models. Here is how NexturnBioscience Co. (089140) and NIBE Industrier AB (publ) (NIBE-B) compare, as of Aug 20, 2026.

As of Aug 20, 2026, Fair Value Calculator sees NIBE Industrier AB (publ) as the more attractively valued of the two: NexturnBioscience Co. trades at KRW 2,275 versus a fair value of KRW 1,790 (-21%), while NIBE Industrier AB (publ) trades at SEK 37.96 versus SEK 40.43 (+7%).
NexturnBioscience Co.
089140.KQ · KRW · Industrials
-21%
upside to fair value
overvalued
PriceKRW 2,275
Fair ValueKRW 1,790
Quality26/100
NIBE Industrier AB (publ)
NIBE-B.ST · SEK · Industrials
+7%
upside to fair value
fairly valued
PriceSEK 37.96
Fair ValueSEK 40.43
Quality58/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

NexturnBioscience Co.NIBE Industrier AB (publ)
Valuation
P/E (TTM)29.9×
P/S (TTM)1.76×
P/B2.37×
EV/EBITDA15.7×
PEG1.79×
Dividend yield0.9%
Dividend per shareSEK 0.35
Profitability
10%Net margin6%
-17%Operating margin9%
Return on equity8%
-1%Return on assets4%
Growth
237%Revenue growth (YoY)-0%
44.3%Avg. growth/yr (3Y)0.6%
48.7%Avg. growth/yr (5Y)8.5%
Balance & size
0.05×Debt / equity0.53×
$24MMarket cap$8B
expensiveGrowth qualityhealthy

NexturnBioscience Co. leads: 5 to 2 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

NexturnBioscience Co.of which business quality 25 · market factors 30 NIBE Industrier AB (publ)of which business quality 56 · market factors 38
ProfitabilityMargins and returns on capital today
5
36
Quality GrowthAre margins and returns improving?
91
65
CashflowEarnings quality: real cash, not paper profit
0
51
Fin. StrengthBalance sheet, leverage, solvency risk
28
53
InvestmentDisciplined investing over empire-building
55
66
Low VolatilityCalm price path (market factor)
20
56
MomentumPrice trend over the last 3–12 months (market factor)
36
31
52W MomentumDistance to the 52-week high (market factor)
30
31
Net IssuanceBuybacks instead of dilution
0
82

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

NexturnBioscience Co.

Earnings-BasedKRW 2,286
MultiplesKRW 3,516
Asset-BasedKRW 6,071
Economic ProfitKRW 2,286

0 of 6 models see the stock below the current price.

NIBE Industrier AB (publ)

DCF ModelsSEK 37.40
Earnings-BasedSEK 15.96
Dividend DiscountSEK 5.98
MultiplesSEK 24.27
Asset-BasedSEK 11.37
Growth DCFSEK 45.05
Economic ProfitSEK 12.91
Growth EarningsSEK 24.90

20 of 25 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

NexturnBioscience Co.
Bear KRW 1,660Fair Value KRW 1,790Bull KRW 1,790
KRW 2,275 = current price (white tick)
NIBE Industrier AB (publ)
Bear SEK 26.52Fair Value SEK 40.43Bull SEK 53.42
SEK 37.96 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

NexturnBioscience Co. · Industrials

Quality score26 · bottom 25%
Fair value upside-21% · below median

NIBE Industrier AB (publ) · Industrials

Quality score58 · above median
Fair value upside+7% · above median

Bottom line

As of Aug 20, 2026, Fair Value Calculator sees NIBE Industrier AB (publ) as the more attractively valued of the two: NexturnBioscience Co. trades at KRW 2,275 versus a fair value of KRW 1,790 (-21%), while NIBE Industrier AB (publ) trades at SEK 37.96 versus SEK 40.43 (+7%).

NIBE Industrier AB (publ) has the higher quality score (58/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.